James Elvecrog
Impact in
-
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- Immune Cell Function and Interaction
- Immune cells in cancer
-
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 4
- Cancer Immunotherapy and Biomarkers 3
-
- Immunotherapy and Immune Responses 4
- Immune Response and Inflammation 3
- Co-authors
- Mark A. Tomai (6 shared papers)John P. Vasilakos (4 shared papers)Ashenafi Y. Tilahun (2 shared papers)Christopher B. Fox (3 shared papers)Iwen F. Grigsby (3 shared papers)Simon J. Dovedi (2 shared papers)Andrew J. Leishman (3 shared papers)Robert W. Wilkinson (3 shared papers)
- Journals
- Cancer Research (2 papers)Journal of Controlled Release (1 paper)Journal of Pharmaceutical Sciences (1 paper)npj Vaccines (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)
- Partner nations
- United StatesNetherlandsSingapore
In The Last Decade
James Elvecrog
6 papers receiving 260 citations
Peers
Comparison fields: 5 of 49
- Immunology 179
- Oncology 66
- Microbiology 15
- Parasitology 14
- Infectious Diseases 36
Countries citing papers authored by James Elvecrog
This map shows the geographic impact of James Elvecrog's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Elvecrog with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Elvecrog more than expected).
Fields of papers citing papers by James Elvecrog
This network shows the impact of papers produced by James Elvecrog. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Elvecrog. The network helps show where James Elvecrog may publish in the future.
Co-authors
The 25 scholars most cited alongside James Elvecrog, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 142 | |
| 2 | 2016 | 44 | |
| 3 | 2018 | 31 | |
| 4 | 2017 | 23 | |
| 5 | 2017 | 22 | |
| 6 | 2018 | 1 | |
| 7 | 2016 | 0 |
About James Elvecrog
James Elvecrog is a scholar working on Oncology, Immunology, Infectious Diseases, Surgery and Small Animals, having authored 7 papers that have together received 263 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immune Response and Inflammation (3 papers), Amoebic Infections and Treatments (2 papers), Parasitic Infections and Diagnostics (1 paper), Viral gastroenteritis research and epidemiology (1 paper), Hepatitis Viruses Studies and Epidemiology (1 paper) and Diagnosis and treatment of tuberculosis (1 paper). The work is most often cited by research in Immunology (179 citations), Oncology (66 citations), Microbiology (15 citations), Parasitology (14 citations) and Infectious Diseases (36 citations). James Elvecrog has collaborated with scholars based in United States, Netherlands and Singapore. Frequent co-authors include Mark A. Tomai, John P. Vasilakos, Ashenafi Y. Tilahun, Christopher B. Fox, Iwen F. Grigsby, Simon J. Dovedi, Andrew J. Leishman, Robert W. Wilkinson, Matthew J. Elder and Stefanie Mullins. Their work appears in journals such as Cancer Research, Journal of Controlled Release, Journal of Pharmaceutical Sciences, npj Vaccines and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.